Werneburg, Glenn T.
Lundy, Scott D.
Hettel, Daniel
Bajic, Petar
Gill, Bradley C.
Adler, Ava
Mukherjee, Sromona D.
Wood, Hadley M.
Angermeier, Kenneth W.
Shoskes, Daniel A.
Miller, Aaron W.
Article History
Received: 23 November 2022
Accepted: 14 July 2023
First Online: 17 July 2023
Competing interests
: GTW has nothing to disclose. wernebg@ccf.org, SDL has nothing to disclose. lundys@ccf.org, DH has nothing to disclose. hetteld@ccf.org, PB has nothing to disclose. bajicp@ccf.org, BG—Consultant/Advisor for Boston Scientific; Consultant for Urovant. gillb@ccf.org, AA has nothing to disclose. adlera3@ccf.org, SM has nothing to disclose. mukhers@ccf.org, HW is site principal investigator for Boston Scientific. woodh@ccf.org, KWA—Consultant for Boston Scientific angermk@ccf.org, DS has investment in Triurol and is full-time employee at ExactSciences. dshoskes@mac.com. AWM has nothing to disclose. millera25@ccf.org.